| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOTIME INC | 20,084 | 17,000 | 0.00% | ||
| 2 | CYCLACEL PHARMACEUTICALS INC | 13,253 | 90,000 | 0.00% | ||
| 3 | CHEMOCENTRYX INC | 49,064 | 296,000 | 0.00% | ||
| 4 | LA JOLLA PHARMACEUTICAL CO | 13,746 | 327,000 | 0.00% | ||
| 5 | Sierra Oncology, Inc. | 200,000 | 364,000 | 0.00% | ||
| 6 | CYTRX CORP | 659,995 | 388,000 | 0.00% | ||
| 7 | ACHAOGEN INC COM | 100,000 | 479,000 | 0.00% | ||
| 8 | Foundation Medicine | 20,892 | 488,000 | 0.00% | ||
| 9 | BIODELIVERY SCIENCES INTL IN | 210,021 | 567,000 | 0.01% | ||
| 10 | ABEONA THERAPEUTICS INC | 101,680 | 610,000 | 0.01% | ||
| 11 | ARBUTUS BIOPHARMA CORP | 180,582 | 621,000 | 0.01% | ||
| 12 | CHIMERIX INC | 115,216 | 638,000 | 0.01% | ||
| 13 | WINDTREE THERAPEUTICS INC | 254,973 | 653,000 | 0.01% | ||
| 14 | RITTER PHARMACEUTICALS INC | 400,000 | 672,000 | 0.01% | ||
| 15 | ADAPTIMMUNE THERAPEUTICS PLC | 100,000 | 705,000 | 0.01% | ||
| 16 | MADRIGAL PHARMACEUTICALS INC | 57,762 | 732,000 | 0.01% | ||
| 17 | ALNYLAM PHARMACEUTICALS INC | 11,340 | 769,000 | 0.01% | ||
| 18 | DYNAVAX TECHNOLOGIES CORP | 75,000 | 787,000 | 0.01% | ||
| 19 | INFINITY PHARMACEUTICALS INC | 580,400 | 905,000 | 0.01% | ||
| 20 | APTOSE BIOSCIENCES INC | 404,211 | 909,000 | 0.01% | ||
| 21 | MAST THERAPEUTICS INC COM | 8,584,051 | 944,000 | 0.01% | ||
| 22 | TENAX THERAPEUTICS INC | 420,000 | 972,000 | 0.01% | ||
| 23 | FIVE PRIME THERAPEUTICS INC | 19,247 | 1,010,000 | 0.01% | ||
| 24 | ACCELERON PHARMA INC | 28,765 | 1,041,000 | 0.01% | ||
| 25 | Aldeyra Therapeutics Inc | 142,000 | 1,110,000 | 0.01% | ||
| 26 | AFFIMED N V COM | 400,000 | 1,112,000 | 0.01% | ||
| 27 | IMMUNE DESIGN CORP | 148,937 | 1,129,000 | 0.01% | ||
| 28 | FULGENT GENETICS INC | 125,000 | 1,153,000 | 0.01% | ||
| 29 | COLUCID PHARMACEUTICALS ORD | 30,310 | 1,156,000 | 0.01% | ||
| 30 | CELLECTIS S A | 50,000 | 1,204,000 | 0.01% | ||
| 31 | PALATIN TECHNOLOGIES INC COM | 2,050,000 | 1,289,000 | 0.01% | ||
| 32 | SERES THERAPEUTICS INC | 125,000 | 1,536,000 | 0.01% | ||
| 33 | MYOKARDIA INC | 100,000 | 1,634,000 | 0.01% | ||
| 34 | OPHTHOTECH CORP | 35,649 | 1,644,000 | 0.01% | ||
| 35 | MEDIWOUND ORD | 226,000 | 1,740,000 | 0.02% | ||
| 36 | UNIQURE NV | 230,000 | 1,760,000 | 0.02% | ||
| 37 | ASSEMBLY BIOSCIENCES INC | 250,000 | 1,803,000 | 0.02% | ||
| 38 | SCYNEXIS INC | 467,600 | 1,810,000 | 0.02% | ||
| 39 | ENANTA PHARMACEUTICALS INC | 75,357 | 2,005,000 | 0.02% | ||
| 40 | IONIS PHARMACEUTICALS INC COM | 57,140 | 2,094,000 | 0.02% | ||
| 41 | KARYOPHARM THERAPEUTICS INC COM | 216,990 | 2,111,000 | 0.02% | ||
| 42 | EPIZYME INC COM | 232,481 | 2,288,000 | 0.02% | ||
| 43 | PROTALIX BIOTHERAPEUTICS INC | 3,423,000 | 2,294,000 | 0.02% | PRN | |
| 44 | JUNO THERAPEUTICS INC COM | 80,000 | 2,401,000 | 0.02% | ||
| 45 | ADR - Nabriva Therapeutics AG- Usd | 350,000 | 2,468,000 | 0.02% | ||
| 46 | OSIRIS THERAPEUTICS INC NEW COM | 499,193 | 2,476,000 | 0.02% | ||
| 47 | SELECTA BIOSCIENCES INC | 178,950 | 2,550,000 | 0.02% | ||
| 48 | AEGLEA BIOTHERAPEUTICS INC | 404,230 | 2,591,000 | 0.02% | ||
| 49 | ENDOCYTE INC | 868,983 | 2,685,000 | 0.02% | ||
| 50 | INVIVO THERAPEUTICS HLDGS CORPORATION COM NEW | 400,000 | 2,720,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-134352, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
